Fixed drug eruption: pathogenesis and diagnostic tests
- 1 August 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Allergy and Clinical Immunology
- Vol. 9 (4), 316-321
- https://doi.org/10.1097/aci.0b013e32832cda4c
Abstract
Fixed drug eruption is a simplified disease model for elucidating the mechanism(s) of how skin inflammation is induced by skin-resident T cells. In this review, we focus on how the presence of intraepidermal CD8+ T cells resident in the fixed drug eruption lesions can provide exciting new clues to our understanding of pathomechanisms of inflammatory skin diseases. Intraepidermal CD8+ T cells with an effector–memory phenotype resident in fixed drug eruption lesions have a major contributing role in the development of localized tissue damage. Activation of these CD8+ T cells is sufficient for triggering the lesion, however, but not sufficient to cause extensive tissue damage observed in the fully evolved lesions; additional recruitment of CD4+ and CD8+ T cells to a specific tissue site would also contribute to the late stage of lesion development. The influx of regulatory T cells into the epidermis observed in fully evolved lesions would serve to limit harmful immune reactions. Consistent with this, positive patch test reactions are only observed at the site of previous lesions harboring significant numbers of intraepidermal CD8+ T cells. Intraepidermal CD8+ T cells may represent double-edged swords of the skin immune system with protective and destructive capacity.Keywords
This publication has 29 references indexed in Scilit:
- Fixed food eruption caused by asparagusJournal of Allergy and Clinical Immunology, 2005
- Fixed food eruption caused by lactose identified after oral administration of four unrelated drugsJournal of the American Academy of Dermatology, 2005
- Direct Evidence for Interferon-γ Production by Effector-Memory-Type Intraepidermal T Cells Residing at an Effector Site of Immunopathology in Fixed Drug EruptionThe American Journal of Pathology, 2002
- Pathophysiology of fixed drug eruption: the role of skin-resident T cellsCurrent Opinion in Allergy and Clinical Immunology, 2002
- Epidermal T Cells: Their Functional Role and Disease Relevance for DermatologistsJournal of Investigative Dermatology, 1997
- Successful desensitization for treatment of a fixed drug eruption to allopurinolJournal of Allergy and Clinical Immunology, 1996
- T cell receptor (TCR) repertoire and function of human epidermal T cells: restricted TCR Vα-Vβ genes are utilized by T cells residing in the lesional epidermis in fixed drug eruptionClinical and Experimental Immunology, 1996
- TCR γ/δ + Dendritic Epidermal T Cells as Constituents of Skin-Associated Lymphoid TissueJournal of Investigative Dermatology, 1990
- Specificity and function of T cells bearing γδ receptorsImmunology Today, 1988
- Wandering fixed drug eruption: A mucocutaneous reaction to acetaminophenJournal of the American Academy of Dermatology, 1987